LifeBond
Caesarea, Hefa, Israel
About LifeBond
LifeBond is a leader in the development and manufacturing of bio-surgical medical devices for tissue repair that are intended to improve the recovery of patients and to create an environment that supports the body’s natural healing process and promotes tissue repair. Of natural origin, elastic, adhesive, durable and yet absorbable, the company’s devices can be used to fill a long list of unmet surgical needs. LifeBond’s first product, LifeSeal™, is designed to provide staple-line reinforcement in bariatric and colorectal operations. It was recently studied in an international pilot clinical study in Europe. The company’s second pipeline product, LifeMesh™, a self-fixating hernia mesh, is in pre-clinical development. Other pipeline products include tissue adhesives and absorbable hemostats. LifeSeal™, LifeMesh™ and other LifeBond™ products are investigational and have not yet been approved for sale in the US or in any other market. For more information please visit use at: www.life-bond.com
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $10K – $50K
- Total funding: $56.5M
- Funding stage: M&A
- Last round: Series D (Aug 2015)
- Website: life-bond.com
- Phone: 972 4 637 3979
Industries & Categories
Biotechnology, Manufacturing, Medical Device
Social Profiles
Canonical: https://fsome.com/organization/lifebond-2608873 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.